RxDoctor Payments Data

Debra Johnson, APRN

Psychiatric/Mental Health · Elizabethtown, KYNPI 1346586153

Payments from drug & device makers

$991in general payments, 2019–2025

Across 77 payments — averaging $12.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$304
  • AbbVie$277
  • Alkermes, Inc.$148
  • Supernus Pharmaceuticals, Inc.$134
  • Takeda Pharmaceuticals U.S.A., Inc.$51
  • Otsuka America Pharmaceutical, Inc.$50
  • plus $26 from 1 others

What the payments were for

  • Food & beverage$991100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$991 in reported general payments places this provider in the 55th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$35,984
Medicare patients
42
Services billed
573

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl48$66,821
FanaptIloperidone11$37,106
TrintellixVortioxetine Hydrobromide17$14,572
SaphrisAsenapine Maleate11$6,121
Lurasidone Hcl16$4,821
Aripiprazole53$2,894
Vilazodone Hcl29$2,838
Olanzapine61$2,806
Hydroxyzine Hcl132$1,511
Methylphenidate ErMethylphenidate Hcl11$1,310
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine29$1,215
Ziprasidone Hcl34$1,054
Quetiapine Fumarate70$1,003
Zolpidem Tartrate ErZolpidem Tartrate14$996
Buspirone Hcl66$814

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar, Saphris$277$72,94259 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$51$14,57217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Elizabethtown

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →